Results 241 to 250 of about 17,703,275 (296)

New Quinazolin-4(3<i>H</i>)-one Derivatives as Potential Antitumoral Compounds: Synthesis, In Vitro Cytotoxicity Against the HepG2 Cell Line, and In Silico VEGFR-2 Targeting-Based Studies. [PDF]

Molecules
Pele R, Marc G, Tiperciuc B, Ionuț I, Stana A, Moldovan C, Tatomir C, Dragostin OM, Pîrnău A, Vlase L, Ungureanu D, Oniga O.   +11 more
europepmc   +1 more source

Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway. [PDF]

Open Med (Wars)
Nazir N, Waqar A, Zaib Khan A, Ali Khan A, Aziz T, Alasmari AF.   +5 more
europepmc   +1 more source

Design, synthesis, and antiproliferative activity of new 5-ethylsulfonyl-indazole-3-carbohydrazides as dual EGFR/VEGFR-2 kinases inhibitors. [PDF]

J Enzyme Inhib Med Chem
Al-Wahaibi LH, Abou-Zied HA, Mahmoud MA, Youssif BGM, Bräse S, Rabea SM.   +5 more
europepmc   +1 more source

PDCL3 promotes the vasculogenic mimicry of glioma-associated mesenchymal stem cells through VEGFR-2 in glioma environment. [PDF]

iScience
Wang Y, Liu Z, Yi D, Gu S, Peng Z, Wang H, Lv P, Xiang W, Jiang X, Fu P.   +9 more
europepmc   +1 more source

Structure-based molecular screening and dynamic simulation of phytocompounds targeting VEGFR-2: a novel therapeutic approach for papillary thyroid carcinoma. [PDF]

Front Pharmacol
Wang S, Zhang L, Zhang W, Zeng X, Mei J, Xiao W, Yang L.   +6 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers. [PDF]

Future Med Chem
Yousef RG, Eissa IH, Elkady H, M Mehany AB, Abo-Saif MA, Radwan MM, ElSohly MA, Ibrahim IM, Elwan A, El-Zahabi MA.   +9 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

In Silico Analysis of Triamterene as a Potential Dual Inhibitor of VEGFR-2 and c-Met Receptors. [PDF]

J Xenobiot
Lutimba S, Saleem B, Aleem E, Mansour MA.   +3 more
europepmc   +1 more source

Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents. [PDF]

RSC Adv
Chaudhari PJ, Nemade AR, Shirkhedkar AA.
europepmc   +1 more source